FRIDAY, Oct. 10, 2025 (HealthDay News) — A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of ...
The targeted drug niraparib added to hormone therapy slowed cancer growth and symptom progression Signs show the combo might also improve survival Originally published on healthday.com, part of the ...
Abstract: This study explores the potential of Artificial Intelligence (AI) in early screening and prognosis of Dry Eye Disease (DED), aiming to enhance the accuracy of therapeutic approaches for ...
Abstract: This study proposes a new surrogate global optimization algorithm that solves problems with expensive black-box multi-modal objective functions subject to homogeneous evaluation noise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback